logo

For the Inventor, By the Inventor

Westfield, NJ, United States of America

Gerard R Kieczykowski

This inventor holds 9 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1989-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerard R Kieczykowski. Retrieved from https://idiyas.com/inventor/gerard-r-kieczykowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 203(Granted Patents)


Company Filing History:

goldMedal9 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1989-1997

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5668176 - Phenoxyphenylacetic acid derivatives (1997-09-16),
2. 5648491 - Process for producing n-amino-1-hydroxy-alkyl-idene-1,1-bisphosphonic (1997-07-15),
3. 5545734 - Aryl and heteroaryl macrolides having immunosuppressive activity (1996-08-13),
4. 5510517 - Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic (1996-04-23),
5. 5159108 - Process for preparing an antihypercalcemic agent (1992-10-27),
6. 5039819 - Diphosphonate intermediate for preparing an antihypercalcemic agent (1991-08-13),
7. 5019651 - Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (1991-05-28),
8. 4922007 - Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (1990-05-01),
9. 4820818 - Process for the geometric stereoselective dehydration of (1989-04-11),

Title: The Innovations of Gerard R Kieczykowski

Introduction

Gerard R Kieczykowski is a notable inventor based in Westfield, NJ (US), recognized for his contributions to the field of pharmaceuticals. With a total of 9 patents to his name, he has made significant strides in developing compounds that address various cardiovascular disorders.

Latest Patents

Among his latest patents is the development of phenoxyphenylacetic acid derivatives. These compounds exhibit endothelin antagonist activity, making them useful in treating cardiovascular disorders such as hypertension, postischemic renal failure, vasospasm, cerebral and cardiac ischemia, myocardial infarction, endotoxic shock, benign prostatic hyperplasia, and inflammatory diseases including Raynaud's disease and asthma. Another notable patent involves a process for producing n-amino-1-hydroxy-alkyl-idene-1,1-bisphosphonic acid, which further showcases his innovative approach to addressing complex medical issues.

Career Highlights

Gerard R Kieczykowski is currently associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on research and development in the pharmaceutical sector, contributing to advancements that have the potential to improve patient outcomes.

Collaborations

Throughout his career, Kieczykowski has collaborated with esteemed colleagues, including Richard Robert Dauer and Lisa DiMichele. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Gerard R Kieczykowski's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of cardiovascular disorders, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…